TIROSINT Levothyroxine Sodium Oral Solution Recalled for Subpotency
TIROSINT (levothyroxine sodium) oral solution has been recalled nationwide by IBSA Pharma Inc. due to subpotency, with the affected medication containing less active ingredient than labeled.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II classification for a product that may cause adverse health consequences. Subpotency means the medication contains less active ingredient than labeled. No reported illnesses or injuries to date, but the potency deficit poses a risk to therapeutic efficacy.
Plain-English summary
TIROSINT SOL (levothyroxine sodium) oral solution 44 microgram/mL has been recalled nationwide due to subpotency. The affected lots are lot 220553 (expiration 11/2023) and lot 221056 (expiration 04/2024). This is a Class II recall, initiated by IBSA Pharma Inc. on January 30, 2023.
Subpotency means the recalled medication contains less of the active ingredient than labeled. Patients currently using levothyroxine from the affected lots should contact their healthcare provider or pharmacist immediately for guidance on their medication.
The recall was terminated on October 31, 2023. The product was distributed nationwide in the USA by IBSA Pharma Inc., which manufactures the medication in Switzerland. For additional information, patients can contact their healthcare provider or the FDA.
The recalled product
- Product
- TIROSINT (LEVOTHYROXINE SODIUM)
- Brand
- TIROSINT
- Manufacturer
- IBSA PHARMA INC
- Category
- Drug — Thyroid Hormone
- Hazard
- subpotency
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- Lot #: 220553
- Exp. 11/2023
- 221056
- Exp. 04/2024.
UPCs (15)
- 0371858011754
- 0371858013055
- 0371858012553
- 0371858011556
- 0371858015554
- 0371858013550
- 0371858015059
- 0371858014052
- 0371858016056
- 0371858014557
- 0371858010559
- 0371858011358
- 0371858011259
- 0371858011051
- 0371858012058
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · TIROSINT
- ModerateTIROSINT Levothyroxine Oral Solution Recalled for Subpotent Drug Content
FDA (Drugs) · 2023-03-01
- HighLevothyroxine sodium oral solution recalled due to subpotency
FDA (Drugs) · 2023-03-01
- HighPrescription drug TIROSINT levothyroxine recalled for subpotent formulation
FDA (Drugs) · 2023-03-01
- HighFDA Recalls TIROSINT Levothyroxine Sodium Oral Solution for Subpotency
FDA (Drugs) · 2023-03-01
- ModerateTIROSINT levothyroxine sodium oral solution recalled for subpotency nationwide
FDA (Drugs) · 2023-03-01
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27